ACR 2024 Archives - Medical Conferences

Home > Rheumatology > ACR 2024

American College of Rheumatology
14–19 November 2024
Washington DC, USA

ACR presents new guideline for lupus nephritis

Presented By

Dr Lisa Sammaritano, Weill Cornell Medicine, NY, USA

Conference

ACR 2024

Type

News article

22 November 2024 12:17

T2T approach in women with RA can increase fertility

Presented By

Prof. Radboud Dolhain, Erasmus University Medical Center, the Netherlands

Trial

PARA, PreCARA

Conference

ACR 2024

Type

News article

19 November 2024 11:27

Online First

ACR presents new guideline for lupus nephritis

Presented By

Dr Lisa Sammaritano, Weill Cornell Medicine, NY, USA

Conference

ACR 2024

Type

News article

22 November 2024 12:17

Positive results for vagus nerve stimulation in RA

Presented By

Dr John Tesser, Arizona Arthritis & Rheumatology Associates, AZ, USA

Trial

Phase 3, RESET-RA

Conference

ACR 2024

Type

News article

22 November 2024 12:15

Dapirolizumab pegol reduces SLE activity and corticosteroid use

Presented By

Dr Megan Clowse, Duke University, NC, USA

Trial

Phase 3, PHOENYCS GO

Conference

ACR 2024

Type

News article

22 November 2024 12:14

NT-3 inhibitor relieves pain caused by osteoarthritis

Presented By

Prof. Philip Conaghan, University of Leeds, UK

Trial

Phase 2

Conference

ACR 2024

Type

News article

22 November 2024 12:11

Emapalumab rapidly controls MAS in patients with Still’s disease

Presented By

Dr Alexei Grom, Cincinnati Children’s Hospital, OH, USA

Trial

NI-0501-06, EMERALD

Conference

ACR 2024

Type

News article

22 November 2024 12:09

Favourable benefit-risk profile of upadacitinib in giant cell arteritis

Presented By

Prof. Peter Merkel, University of Pennsylvania, PA, USA

Trial

Phase 3, SELECT-GCA

Conference

ACR 2024

Type

News article

21 November 2024 15:21

Global recruitment associated with higher placebo responses in PsA trials

Presented By

Dr Andreas Kerschbaumer, Medical University of Vienna, Austria

Conference

ACR 2024

Type

News article

21 November 2024 15:19

TAPIR: Fully tapering off glucocorticosteroids may be a viable option for GPA

Presented By

Prof. Peter Merkel, University of Pennsylvania, PA, USA

Trial

Phase 3, TAPIR

Conference

ACR 2024

Type

News article

21 November 2024 15:16

ICI therapy does not increase mortality risk in patients with pre-existing autoimmune disease

Presented By

Dr Greg Challener, Massachusetts General Hospital, MA, USA

Conference

ACR 2024

Type

News article

21 November 2024 15:15

XG005 relieves OA symptoms in phase 2b study

Presented By

Dr Leon Jiang, Xgene Pharmaceutical Lexington, MA, USA

Trial

Phase 2

Conference

ACR 2024

Type

News article

21 November 2024 15:13

FcRn blocker nipocalimab improves disease activity in Sjögren’s disease

Presented By

Dr Ghaith Noaiseh, University of Kansas Medical Center, KS, USA

Trial

Phase 2, DAHLIAS

Conference

ACR 2024

Type

News article

19 November 2024 11:59

Anifrolumab more effective against organ damage than standard-of-care in SLE

Presented By

Dr Zahi Touma, University of Toronto, Canada

Trial

LASER, TULIP-1, TULIP-2

Conference

ACR 2024

Type

News article

19 November 2024 11:29

T2T approach in women with RA can increase fertility

Presented By

Prof. Radboud Dolhain, Erasmus University Medical Center, the Netherlands

Trial

PARA, PreCARA

Conference

ACR 2024

Type

News article

19 November 2024 11:27

Post-hoc analysis of 3 large trials maps sex differences in PsA

Presented By

Dr Laura Coates, University of Oxford, UK

Trial

DISCOVER-1, DISCOVER-2, COSMOS

Conference

ACR 2024

Type

News article

19 November 2024 11:25

Registry participation can enhance quality of rheumatology care

Presented By

Dr Gabriela Schmajuk, University of California, San Francisco, CA, USA

Conference

ACR 2024

Type

News article

19 November 2024 11:23

Medical Conferences

ACR 2024

Featured articles

ACR presents new guideline for lupus nephritis

T2T approach in women with RA can increase fertility

CONTENTS

Online First

ACR presents new guideline for lupus nephritis

Positive results for vagus nerve stimulation in RA

Dapirolizumab pegol reduces SLE activity and corticosteroid use

NT-3 inhibitor relieves pain caused by osteoarthritis

Emapalumab rapidly controls MAS in patients with Still’s disease

Favourable benefit-risk profile of upadacitinib in giant cell arteritis

Global recruitment associated with higher placebo responses in PsA trials

TAPIR: Fully tapering off glucocorticosteroids may be a viable option for GPA

ICI therapy does not increase mortality risk in patients with pre-existing autoimmune disease

XG005 relieves OA symptoms in phase 2b study

FcRn blocker nipocalimab improves disease activity in Sjögren’s disease

Anifrolumab more effective against organ damage than standard-of-care in SLE

T2T approach in women with RA can increase fertility

Post-hoc analysis of 3 large trials maps sex differences in PsA

Registry participation can enhance quality of rheumatology care